Macular Degeneration Clinical Trials

Find clinical trials for macular degeneration. Search for macular degeneration clinical trials in different cities and states across the United States.

Filter

Filter results

Results: 124

EC-104EC-104 Intravitreal Implant for the Treatment of Diabetic Macular Edema

Recruiting

PHASE1

PHASE2

Sponsor:

Eclipse Life Sciences, Inc.

Location:

Tampa FL

Code:

NCT06536491

Conditions

Diabetic Macular Edema

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

EC-104 high dose

EC-104 low dose

Dexamethasone intravitreal implant

OCU410STStudy to Assess the Safety and Efficacy of OCU410ST for Stargardt Disease

Recruiting

PHASE1

PHASE2

Sponsor:

Ocugen

Location:

Phoenix AZ, Miami FL, Jackson MS, Durham NCshow 2 more

Code:

NCT05956626

Conditions

Stargardt Disease

Eligibility Criteria

Sex: All

Age: 6 - 65

Healthy Volunteers: Not accepted

Interventions

OCU410ST

N-acetylcysteineOral N-acetylcysteine for Retinitis Pigmentosa

Recruiting

PHASE3

Sponsor:

Johns Hopkins University

Location:

Davis CA, Los Angeles CA, San Francisco CA, Stanford CAshow 21 more

Code:

NCT05537220

Conditions

Retinitis Pigmentosa

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

N-acetylcysteine

Placebo

JNJ-81201887A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

Recruiting

PHASE2

Sponsor:

Janssen Research & Development, LLC

Location:

Tucson AZ, Fullerton CA, La Jolla CA, Poway CAshow 29 more

Code:

NCT06635148

Conditions

Geographic Atrophy

Macular Degeneration

Eligibility Criteria

Sex: All

Age: 60+

Healthy Volunteers: Not accepted

Interventions

JNJ-81201887

Sham Procedure

Avacincaptad PegolA Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy

Recruiting

Sponsor:

Astellas Pharma Global Development, Inc.

Location:

Phoenix AZ, Scottsdale AZ, Redlands CA, Altamonte Springs FLshow 7 more

Code:

NCT06779773

Conditions

Geographic Atrophy

Macular Degeneration

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Avacincaptad pegol (ACP)

ElamipretideReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD)

Recruiting

PHASE3

Sponsor:

Stealth BioTherapeutics Inc.

Location:

Phoenix AZ, Sun City AZ, Huntington Beach CA, Poway CAshow 30 more

Code:

NCT06373731

Conditions

Age Related Macular Degeneration (ARMD)

Eligibility Criteria

Sex: All

Age: 55+

Healthy Volunteers: Not accepted

Interventions

Elamipretide

Placebo

RanibizumabCytokine and Visual Outcome Variations in Eyes Receiving Ranibizumab

Recruiting

Sponsor:

Unity Health Toronto

Location:

Toronto

Code:

NCT03056092

Conditions

Age Related Macular Degeneration

Diabetic Macular Edema

Macular Edema

Retinal Vein Occlusion

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Intravitreal ranibizumab

OCU-10-C-110Safety and Tolerability of OCU-10-C-110 for Injection in Subjects With Neovascular Age-related Macular Degeneration

Recruiting

PHASE1

Sponsor:

Ocugenix Corporation

Location:

Carmel IN, Abilene TX, Willow Park TX

Code:

NCT05904691

Conditions

Neovascular Age-related Macular Degeneration (nAMD)

Eligibility Criteria

Sex: All

Age: 50+

Healthy Volunteers: Not accepted

Interventions

OCU-10-C-110 for Injection

NG101NG101 AAV Gene Therapy in Subjects with Wet Age-Related Macular Degeneration

Recruiting

PHASE1

PHASE2

Sponsor:

Neuracle Genetics, Inc

Location:

Cincinnati OH, Vancouver, Toronto

Code:

NCT05984927

Conditions

Age-Related Macular Degeneration

Eligibility Criteria

Sex: All

Age: 50 - 70+

Healthy Volunteers: Not accepted

Interventions

NG101 AAV gene therapy

IAI vs. ShamIAI Versus Sham as Prophylaxis Against Conversion to Neovascular AMD

Recruiting

PHASE2

Sponsor:

Jeffrey S Heier

Location:

Beverly Hills CA, Boston MA, Edison NJ, Houston TX

Code:

NCT02462889

Conditions

Age-Related Macular Degeneration

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Intravitreal aflibercept injection

Placebo